Detalhe da pesquisa
1.
[A randomized controlled study of erlotinib versus pemetrexed combined with cisplatin in neoadjuvant therapy of stage â ¢A EGFR-mutant lung adenocarcinoma].
Zhonghua Zhong Liu Za Zhi
; 40(2): 133-137, 2018 Feb 23.
Artigo
em Zh
| MEDLINE | ID: mdl-29502374